HOXA9 Antikörper (N-Term)
Kurzübersicht für HOXA9 Antikörper (N-Term) (ABIN6252036)
Target
Alle HOXA9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Protein A Affinity Chromatography
-
Immunogen
- A recombinant protein fragment from the N-terminal region of human HOXA9 was used as the immunogen for this antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Western blot: 2-5 μg/mL
Provided assay concentrations are suggestions only, HOXA9 antibody titration may be required for optimal results. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- PBS with 0.1 mg/mL BSA and 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and Store at -20C. Avoid freez-thaw cycles.
-
-
- HOXA9 (Homeobox A9 (HOXA9))
-
Andere Bezeichnung
- HOXA9
-
Hintergrund
- HOXA9 is part of the A cluster of the homeobox family of DNA-binding transcription factors. This protein may play a role in gene expression, morphogenesis, and embryonic development. It and the fusion oncogene NUP98-HOXA9 have been implicated in leukemia. SMAD4 has been shown to negatively regulate HOXA9-mediated leukemia stem cell growth.
-
Gen-ID
- 3205
-
UniProt
- P31269
Target
-